ArticleVeterinary research2025
Salvianolic acid A inhibits PRRSV replication via binding to Keap1 to activate the MKRN1-Nrf2-NQO1 pathway.
Article in Veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mechanism of Scutellaria baicalensis extracellular vesicles in attenuating Mycoplasma gallisepticum-induced inflammation via TRPC1 - STIM1/ORAI1 channel inhibition.Poultry science · 2026Article
- Salvianolic acid A exerts antiviral effects by targeting the S protein, a virulence factor of porcine epidemic diarrhea virus.Journal of virology · 2026Article
- Chinese Herbal Medicines for Diabetic Cardio-Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms.Journal of nutrition and metabolism · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Porcine reproductive and respiratory syndrome (PRRS) has caused significant economic losses to the global pig industry, and there are currently no safe, effective, or commercially available vaccines. Traditional Chinese medicine may serve as a beneficial supplement to vaccines and provide a feasible solution for preventing and controlling PRRS. The present study explored the effects and molecular mechanisms of the traditional Chinese medicine Salviae miltiorrhizae Bunge extract salvianolic acid A (SalA) on porcine reproductive and respiratory syndrome virus (PRRSV) replication. SalA effectively inhibited PRRSV replication in vitro and in vivo without affecting the adsorption, entry, or release stages of the viral replication cycle. SalA directly binds to the Thr560 site of Kelch-like ECH-associated protein 1 (Keap1) via a hydrogen bond, promoting the recruitment of Keap1 to a newly identified E3 ubiquitin ligase, makorin RING finger protein 1 (MKRN1). This led to K48-linked ubiquitination of Keap1 at the K615 amino acid residue, subsequent proteasomal degradation, and eventual activation of the nuclear factor E2-related factor 2 (Nrf2)-NADPH quinone oxidoreductase 1 (NQO1) pathway. Knockdown of MKRN1 blocked SalA-induced Keap1 ubiquitination, degradation, and activation of the Nrf2-NQO1 pathway. Further viral infection experiments revealed that SalA inhibited PRRSV replication by activating the MKRN1-Nrf2-NQO1 pathway. In addition to its anti-PRRSV activity, SalA effectively inhibited PRRSV- and lipopolysaccharide (LPS)-induced expression of inflammatory cytokines, activation of inflammatory pathways and inflammasomes, and inhibition of cellular pyroptosis by activating the Nrf2 pathway. These results suggest that SalA can inhibit PRRSV replication and alleviate the inflammatory response during PRRS and secondary bacterial infections, providing a novel candidate strategy for PRRS treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.